Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression (Q34013976)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression |
scientific article |
Statements
1 reference
Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression (English)
1 reference
Xuchao Zhang
1 reference
Shirley Zhang
1 reference
Xuening Yang
1 reference
Jinji Yang
1 reference
Qing Zhou
1 reference
Lucy Yin
1 reference
Shejuan An
1 reference
Jiaying Lin
1 reference
Shiliang Chen
1 reference
Zhi Xie
1 reference
Mike Zhu
1 reference
Xiaolin Zhang
1 reference
Yi-long Wu
1 reference
13 July 2010
1 reference
1 reference
188
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference